<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Global Health Hub: news and blogosphere aggregator &#187; Cancer</title>
	<atom:link href="http://www.globalhealthhub.org/category/noncommunicable-disease/cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.globalhealthhub.org</link>
	<description>Keeping up with global health &#38; development news, blogosphere, forums, events, jobs and more</description>
	<lastBuildDate>Wed, 22 May 2013 04:00:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>A Role for NGOs in Cancer Care in Latin America: Patient Accompaniment</title>
		<link>http://www.globalhealthhub.org/2013/05/20/a-role-for-ngos-in-cancer-care-in-latin-america-patient-accompaniment/</link>
		<comments>http://www.globalhealthhub.org/2013/05/20/a-role-for-ngos-in-cancer-care-in-latin-america-patient-accompaniment/#comments</comments>
		<pubDate>Mon, 20 May 2013 13:13:05 +0000</pubDate>
		<dc:creator>Peter_Rohloff</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Featured Content]]></category>
		<category><![CDATA[Hub Full-Length Features]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Human Rights]]></category>
		<category><![CDATA[misc]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[Policy & Systems]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=97055</guid>
		<description><![CDATA[This is a guest post by Anita Chary. Anita is an MD/PhD student in anthropology at Washington University in St. Louis. She is also the research director for Wuqu&#8217; Kawoq &#124; Maya Health Alliance. Cancer rates are rapidly rising in Latin American countries, according to a recent report published in the Lancet [1]. Low- and [...]]]></description>
				<content:encoded><![CDATA[<p><div id="attachment_97059" class="wp-caption alignleft" style="width: 310px"><a href="http://www.globalhealthhub.org/wp-content/uploads/2013/05/GEDC0051.jpg"><img src="http://www.globalhealthhub.org/wp-content/uploads/2013/05/GEDC0051-300x225.jpg" alt="José translates instructions about how to take anti-nausea medications after chemotherapy into Dominga’s native language, Kaqchikel." width="300" height="225" class="size-medium wp-image-97059" /></a><p class="wp-caption-text">José translates instructions about how to take anti-nausea medications after chemotherapy into Dominga’s native language, Kaqchikel.</p></div><em>This is a guest post by <a href="mailto:anita.chary@gmail.com">Anita Chary</a>. Anita is an MD/PhD student in anthropology at Washington University in St. Louis. She is also the research director for <a href="http://www.wuqukawoq.org">Wuqu&#8217; Kawoq | Maya Health Alliance.</a></em></p>
<p>Cancer rates are rapidly rising in Latin American countries, according to a recent report published in the Lancet [1].  Low- and middle-income countries of Latin America have a lower overall prevalence of cancer, but higher cancer death rates, than developed nations.  This disparity can be largely explained by several common themes in cancer care provision throughout Latin America: late diagnoses, poor access to treatment, and limited availability of efficacious therapies.</p>
<p>Guatemala faces many of the challenges that beset Latin American countries in cancer care.  Geographic, economic, and linguistic barriers conspire to restrict access to cancer therapy for a large portion of the population.  Guatemala’s National Cancer Hospital [Instituto de Cancerología, INCAN], the nation’s only institution that provides cancer care to the public sector, is located in the capital, Guatemala City.  Patients living in other areas of the country—particularly rural areas—must travel anywhere from several hours to several days to reach the hospital.  Although INCAN receives some funding from the Guatemalan Ministry of Health to offset the costs of patients’ initial laboratory exams and diagnostic procedures, patients must pay for the majority of their treatment costs, which are all too often prohibitively expense.  While the majority of Guatemala’s population is indigenous and 23 indigenous languages are spoken in the country [2], all services at INCAN are delivered in Spanish.  On top of these issues, the hospital itself suffers from an enormous backlog of 1200+ patients on the waiting list for radiotherapy services.  These problems are intimately linked to poor follow-up care and patient retention rates.  According to the director of the hospital, Dr. Walter Guerra, 33% of patients who receive a cancer diagnosis at INCAN never begin treatment; 33% of patients start, but do not finish, therapy; and only 33% of patients complete the recommended course of therapy.  These statistics are worse for indigenous patients with cancer, 50% of whom never begin treatment after initial diagnosis.</p>
<p>In the midst of these challenges, the non-governmental sector has come to represent an important source of health care for many Guatemalans [2-4].  In Guatemala alone, there are an estimated 10,000 to 15,000 non-governmental organizations [NGOs], many of which are involved in health care provision to varying degrees [2].  Other Latin American countries, such as Bolivia, El Salvador, and Mexico, have experienced similar explosions in the NGO sector in recent years, in light of global economic policies encouraging the privatization of social services [5-7].</p>
<p>Private sector health organizations could play a crucial role in increasing the number of patients who make it all the way through treatment.  Take the case of Dominga Puac*, a 60-year-old woman who was diagnosed with cervical cancer three years ago.  Dominga is a monolingual speaker of the Mayan language Kaqchikel.  She lives in a small adobe house in a rural hamlet of the highland town of San Juan Comalapa, and supports herself through subsistence agriculture, farming a small plot of land adjacent to her home.  In 2010, Dominga began to experience vaginal hemorrhage.  After seeking care at the local government health center in San Juan Comalapa, Dominga was referred to INCAN.</p>
<p>Public transportation from Dominga’s village to San Juan Comalapa is only available once a week, and as such, Dominga planned well in advance the four-hour journey to the capital.  When she arrived at INCAN for an initial consultation, she barely understood what the Spanish-speaking doctors there told her.  She completed required initial laboratory exams, whose costs were already beyond her means, only to receive a staggering estimate of treatment costs for several thousand quetzales—more money than she sees in one year.  Lacking the ability to pay for the services, she did not return to INCAN for her first chemotherapy appointment.</p>
<p>Over the next year, the hemorrhage worsened.  Dominga grew increasingly concerned and desperate.  With the help of relatives and village officials, Dominga reached out to Maya Health Alliance, a non-governmental organization (NGO) that sponsors a nutrition and primary health care program in a nearby village.  After initial evaluation by a physician, Dominga was enrolled in the NGO’s Complex Care Program, which attends to rural patients with specialized health care needs ranging from pediatric heart surgeries to dialysis to cancer care.  Through this program, Maya Health Alliance currently funds treatment for about 75 patients who require treatments in tertiary care centers in Guatemala City.  Sometimes, the costs of treatment are covered in conjunction with other NGOs or charities, and local Guatemalan institutions collaborate with Maya Health Alliance by offering services at- or marginally above-cost.</p>
<p>Addressing economic barriers to care, however, is only one component of Maya Health Alliance’s Complex Care Program.  Fulltime staff member José Cali works to address the cultural and logistical barriers to care, which would otherwise represent formidable obstacles for patients from rural and indigenous areas of Guatemala.  José, who is bilingual in Kaqchikel and Spanish, takes care of the nitty-gritty details of scheduling consultations, transportation, and language interpretation. </p>
<p><div id="attachment_97063" class="wp-caption alignleft" style="width: 235px"><a href="http://www.globalhealthhub.org/wp-content/uploads/2013/05/GEDC0025.jpg"><img src="http://www.globalhealthhub.org/wp-content/uploads/2013/05/GEDC0025-225x300.jpg" alt="Staff member José Cali begins his day at INCAN by reviewing the cases of the six patients whose care he will be managing for the day." width="225" height="300" class="size-medium wp-image-97063" /></a><p class="wp-caption-text">Staff member José Cali begins his day at INCAN by reviewing the cases of the six patients whose care he will be managing for the day.</p></div><br />
In Dominga’s case, for example, José arranges her medical appointments at INCAN and reminds her of them, days in advance and the day before, encouraging her to attend.  As José drives to the capital on a daily basis from a nearby highland town, he provides Dominga with transportation for her chemotherapy and radiotherapy sessions.  He attends consultations with Dominga, translating physicians’ questions into Kaqchikel for Dominga, and translating Dominga’s responses into Spanish for physicians, clarifying doubts on both ends and ensuring adequate patient-provider communication.  When Dominga, who cannot read or write, is sent to obtain exams and procedures in different departments of the hospital, José navigates the complex with her to ensure that she ends up in the correct place.  And between treatments, José calls Dominga to inquire about her health; he arranges for a health care provider of Maya Health Alliance to conduct a home visit in case of medical complications, and he follows up with any required laboratory work or hospitalizations.  To date, Dominga has gone through several rounds of chemotherapy and is recovering quite well.</p>
<p>The philosophy of patient accompaniment has long been recognized by health organizations, such as Partners in Health and the American Cancer Society, as a crucial step towards breaking down barriers to care for impoverished and underserved patients.  In the realm of cancer care, a handful of other NGOs in Guatemala with similar programming to that of Maya Health Alliance can attest to this fact.  Even when NGOs do not fund patients’ therapy or provide only partial funding, the logistical support in transportation, communication, and follow-up visits that they offer can spell the difference between a patient abandoning and finishing cancer treatment.  By accompanying patients through care, non-governmental organizations could play an important role in reducing cancer disparities and deaths in Guatemala and, more broadly, Latin America.  </p>
<p>&#8211;<br />
References<br />
[1] Lancet Oncology.  2013.  Abstract.  14:391-436.<br />
[2] Rohloff, P, Kraemer Díaz, A, and Dasgupta, S.  2011. “Beyond development”: A critical appraisal of the emergence of small health care non governmental organizations in rural Guatemala.  Human Organization 70(4):427-437.<br />
[3] Maupin, JN.  2009.  “Fruit of the Accords”: Health Care Reform and Civil Participation in Highland Guatemala.  Social Science and Medicine 68(8):1456-63.<br />
[4] Cardelle, AJ.  2003.  Health Care Reform in Central America: NGO-Government Collaboration in Guatemala and El Salvador.  Miami, FL: North-South Center Press.<br />
[5] Gill, L.  2000.  Teetering on the Rim: Global Restructuring, Daily Life, and the Armed Retreat of the Bolivian State.  New York: Columbia University Press.<br />
[6] Smith-Nonini, S.  2010.  Healing the Body Politic: El Salvador’s Popular Struggle for Health Rights from Civil War to Neoliberal Peace.  New Brunswick, New Jersey: Rutgers University Press.<br />
[7] Schneider, SD.  2010  Mexican Community Health and the Politics of Health Reform.  Albuquerque, NM: University of New Mexico Press.</p>
<p>&#8211;</p>
<p>*Pseudonym.<br />
Dominga and José gave permission for their photos to be used in this post.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/20/a-role-for-ngos-in-cancer-care-in-latin-america-patient-accompaniment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Influence of health rights discourses and community organizing on equitable&#8230;</title>
		<link>http://www.globalhealthhub.org/2013/05/17/influence-of-health-rights-discourses-and-community-organizing-on-equitable/</link>
		<comments>http://www.globalhealthhub.org/2013/05/17/influence-of-health-rights-discourses-and-community-organizing-on-equitable/#comments</comments>
		<pubDate>Fri, 17 May 2013 07:00:00 +0000</pubDate>
		<dc:creator>GlobalizationAndHealth</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Journal Watch]]></category>
		<category><![CDATA[Tuberculosis]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[tuberculosis]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/2013/05/17/influence-of-health-rights-discourses-and-community-organizing-on-equitable/</guid>
		<description><![CDATA[Background: The right to health is recognized as a fundamental human right. Social participation is implied in the fulfillment of health rights since Alma Ata posited its relevance for successful health programs, although a wide range of interpretations has been observed for this term. While Peruvian law recognizes community and social participation in health, it was the GFATM requirement of mixed public-civil society participation in Country Coordination Mechanisms (CCM) for proposal submission what effectively led to formal community involvement in the national response to HIV and, to a lesser extent, tuberculosis. This has not been the case, however, for other chronic diseases in Peru. This study aims to describe and compare the role of health rights discourse and community involvement in the national response to HIV, tuberculosis and cancer]]></description>
				<content:encoded><![CDATA[</p>
<p>Background: The right to health is recognized as a fundamental human right. Social participation is implied in the fulfillment of health rights since Alma Ata posited its relevance for successful health programs, although a wide range of interpretations has been observed for this term. While Peruvian law recognizes community and social participation in health, it was the GFATM requirement of mixed public-civil society participation in Country Coordination Mechanisms (CCM) for proposal submission what effectively led to formal community involvement in the national response to HIV and, to a lesser extent, tuberculosis. This has not been the case, however, for other chronic diseases in Peru. This study aims to describe and compare the role of health rights discourse and community involvement in the national response to HIV, tuberculosis and cancer</p>
<p>More here - </p>
<p><a target="_blank" href="http://www.globalizationandhealth.com/content/9/1/23" title="Influence of health rights discourses and community organizing on equitable...">Influence of health rights discourses and community organizing on equitable&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/17/influence-of-health-rights-discourses-and-community-organizing-on-equitable/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cervical Cancer Vaccine Success Brings Hope to Millions of Women</title>
		<link>http://www.globalhealthhub.org/2013/05/16/cervical-cancer-vaccine-success-brings-hope-to-millions-of-women/</link>
		<comments>http://www.globalhealthhub.org/2013/05/16/cervical-cancer-vaccine-success-brings-hope-to-millions-of-women/#comments</comments>
		<pubDate>Thu, 16 May 2013 14:41:00 +0000</pubDate>
		<dc:creator>GatesFoundationBlog</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[cancer]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=96591</guid>
		<description><![CDATA[Excerpt from: Cervical Cancer Vaccine Success Brings Hope to Millions of Women]]></description>
				<content:encoded><![CDATA[</p>
<p><img src="http://www.globalhealthhub.org/wp-content/uploads/2013/05/fca53a02c3de0722ef582__autocropped_lat_autocropped.jpg" /></p>
<p>Excerpt from:<br />
<a target="_blank" href="http://www.impatientoptimists.org/Posts/2013/05/Cervical-Cancer-Vaccine-Success-Brings-Hope-to-Millions-of-Women" title="Cervical Cancer Vaccine Success Brings Hope to Millions of Women">Cervical Cancer Vaccine Success Brings Hope to Millions of Women</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/16/cervical-cancer-vaccine-success-brings-hope-to-millions-of-women/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Daily Impact: India Develops Promising Rotavirus Vaccine</title>
		<link>http://www.globalhealthhub.org/2013/05/16/the-daily-impact-india-develops-promising-rotavirus-vaccine/</link>
		<comments>http://www.globalhealthhub.org/2013/05/16/the-daily-impact-india-develops-promising-rotavirus-vaccine/#comments</comments>
		<pubDate>Thu, 16 May 2013 14:40:00 +0000</pubDate>
		<dc:creator>PSIHealthyLives</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Infant & Child Health]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Vaccinations]]></category>
		<category><![CDATA[Women & Children]]></category>
		<category><![CDATA[daily impact]]></category>
		<category><![CDATA[rotavirus]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=96614</guid>
		<description><![CDATA[May 16, 2013 Phase III trials of the Rotavac Rotavirus Vaccine show that it has the potential to save thousands of lives, say scientists. From the BBC: Rotavirus causes dehydration and severe diarrhoea and spreads through contaminated hands and surfaces and is rampant in Asia and Africa. India says clinical trials show the new vaccine, Rotavac, can save the lives of thousands of children annually. An Indian manufacturer said the vaccine would cost 54 rupees ($1; £0.65). International pharmaceutical companies GlaxoSmithKline and Merck produce similar vaccines but each dose costs around 1,000 rupees. "This is an important scientific breakthrough against rotavirus infections, the most severe and lethal cause of childhood diarrhoea, responsible for approximately 100,000 deaths of small children in India each year," India's Department of Biotechnology official K Vijay Raghavan said]]></description>
				<content:encoded><![CDATA[<p>May 16, 2013 Phase III trials of the Rotavac Rotavirus Vaccine show that it has the potential to save thousands of lives, say scientists. From the BBC: Rotavirus causes dehydration and severe diarrhoea and spreads through contaminated hands and surfaces and is rampant in Asia and Africa. India says clinical trials show the new vaccine, Rotavac, can save the lives of thousands of children annually. An Indian manufacturer said the vaccine would cost 54 rupees ($1; £0.65). International pharmaceutical companies GlaxoSmithKline and Merck produce similar vaccines but each dose costs around 1,000 rupees. &#8220;This is an important scientific breakthrough against rotavirus infections, the most severe and lethal cause of childhood diarrhoea, responsible for approximately 100,000 deaths of small children in India each year,&#8221; India&#8217;s Department of Biotechnology official K Vijay Raghavan said</p>
<p><img src="http://www.globalhealthhub.org/wp-content/uploads/2013/05/31515559524166_510ebb57a0_n-150x150.jpg" /></p>
<p>Go here to read the rest:<br />
<a target="_blank" href="http://blog.psiimpact.com/2013/05/the-daily-impact-india-develops-promising-rotavirus-vaccine/" title="The Daily Impact: India Develops Promising Rotavirus Vaccine">The Daily Impact: India Develops Promising Rotavirus Vaccine</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/16/the-daily-impact-india-develops-promising-rotavirus-vaccine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Breaking Breast Cancer Taboos</title>
		<link>http://www.globalhealthhub.org/2013/05/16/breaking-breast-cancer-taboos/</link>
		<comments>http://www.globalhealthhub.org/2013/05/16/breaking-breast-cancer-taboos/#comments</comments>
		<pubDate>Thu, 16 May 2013 14:39:00 +0000</pubDate>
		<dc:creator>PRI podcasts</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Featured videos and pod casts]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[Podcasts]]></category>
		<category><![CDATA[cancer]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=96620</guid>
		<description><![CDATA[<p>Hollywood actress Angelina Jolie has undergone a double mastectomy to reduce her chances of getting breast cancer. The 37-year-old mother of six has explained her reasons for having the surgery in a New York Times op-ed. The public announcement "touched my heart," Saudi Arabian doctor Samia Al-Amoudi tells PRI's The World. Al-Amoudi became one of the first Saudi women to go public about her breast cancer in 1996 and has been trying to reduce the stigma of breast cancer across the Arab world ever since. Then on the pod, we travel to Chile where a simple vending machine that dispenses laundry detergent makes a difference in a poor neighborhood. Finally, in Cape Town, South Africa, where Lukhanyo walks two and a quarter miles, through open fields and gang territories, and past areas where petty thieves hang out to get a high-quality education. He says he's an easy target for robbers because of what he's wearing: a school uniform.</p>]]></description>
				<content:encoded><![CDATA[<p><object class="alignleft" type="audio/mpeg" data="http://traffic.libsyn.com/globalhealth/breastcancer.mp3" width="250" height="206"><param name="src" value="http://traffic.libsyn.com/globalhealth/breastcancer.mp3"><param name="autoplay" value="false"><a href="http://traffic.libsyn.com/globalhealth/breastcancer.mp3">http://traffic.libsyn.com/globalhealth/breastcancer.mp3</a></object> </p>
<p>
<p>Hollywood actress Angelina Jolie has undergone a double mastectomy to reduce her chances of getting breast cancer. The 37-year-old mother of six has explained her reasons for having the surgery in a New York Times op-ed. The public announcement &#8220;touched my heart,&#8221; Saudi Arabian doctor Samia Al-Amoudi tells PRI&#8217;s The World. Al-Amoudi became one of the first Saudi women to go public about her breast cancer in 1996 and has been trying to reduce the stigma of breast cancer across the Arab world ever since. Then on the pod, we travel to Chile where a simple vending machine that dispenses laundry detergent makes a difference in a poor neighborhood. Finally, in Cape Town, South Africa, where Lukhanyo walks two and a quarter miles, through open fields and gang territories, and past areas where petty thieves hang out to get a high-quality education. He says he&#8217;s an easy target for robbers because of what he&#8217;s wearing: a school uniform.</p>
</p>
<p>Follow this link - </p>
<p><a target="_blank" href="http://traffic.libsyn.com/globalhealth/breastcancer.mp3" title="Breaking Breast Cancer Taboos">Breaking Breast Cancer Taboos</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/16/breaking-breast-cancer-taboos/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://traffic.libsyn.com/globalhealth/breastcancer.mp3" length="0" type="audio/mpeg" />
		</item>
		<item>
		<title>See-and-treat approach can rein in Cambodia&#8217;s cervical cancer death toll</title>
		<link>http://www.globalhealthhub.org/2013/05/14/see-and-treat-approach-can-rein-in-cambodias-cervical-cancer-death-toll/</link>
		<comments>http://www.globalhealthhub.org/2013/05/14/see-and-treat-approach-can-rein-in-cambodias-cervical-cancer-death-toll/#comments</comments>
		<pubDate>Tue, 14 May 2013 19:23:38 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Featured Content]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[Women & Children]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=96275</guid>
		<description><![CDATA[For Cambodia which offers no treatment for cervical cancer apart from palliative care, see-and-treat programmes could radically cut deaths and reduce the burden of disease via See-and-treat approach can rein in Cambodia&#8217;s cervical cancer death toll &#124; Global Development Professionals Network &#124; Guardian Professional.]]></description>
				<content:encoded><![CDATA[<p>For Cambodia which offers no treatment for cervical cancer apart from palliative care, see-and-treat programmes could radically cut deaths and reduce the burden of disease</p>
<p>via <a href="http://www.guardian.co.uk/global-development-professionals-network/2013/may/14/see-and-treat-cervical-cancer-cambodia">See-and-treat approach can rein in Cambodia&#8217;s cervical cancer death toll | Global Development Professionals Network | Guardian Professional</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/14/see-and-treat-approach-can-rein-in-cambodias-cervical-cancer-death-toll/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Africa Has the Highest Cervical Cancer Deaths</title>
		<link>http://www.globalhealthhub.org/2013/05/13/africa-has-the-highest-cervical-cancer-deaths/</link>
		<comments>http://www.globalhealthhub.org/2013/05/13/africa-has-the-highest-cervical-cancer-deaths/#comments</comments>
		<pubDate>Mon, 13 May 2013 13:10:05 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[cervical cancer]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=96081</guid>
		<description><![CDATA[Africa is the most dangerous place to be a woman with cervical cancer. Ten of the countries with the highest cervical cancer mortality rate can be found in Africa. via allAfrica.com: Rwanda: Africa Has the Highest Cervical Cancer Deaths.]]></description>
				<content:encoded><![CDATA[<p>Africa is the most dangerous place to be a woman with cervical cancer. Ten of the countries with the highest cervical cancer mortality rate can be found in Africa.</p>
<p>via <a href="http://allafrica.com/stories/201305131510.html">allAfrica.com: Rwanda: Africa Has the Highest Cervical Cancer Deaths</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/13/africa-has-the-highest-cervical-cancer-deaths/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Iraq: Humanitarian Programme Coordinator, Erbil, Iraq, Arab States Regional&#8230;</title>
		<link>http://www.globalhealthhub.org/2013/05/10/iraq-humanitarian-programme-coordinator-erbil-iraq-arab-states-regional/</link>
		<comments>http://www.globalhealthhub.org/2013/05/10/iraq-humanitarian-programme-coordinator-erbil-iraq-arab-states-regional/#comments</comments>
		<pubDate>Sat, 11 May 2013 06:10:00 +0000</pubDate>
		<dc:creator>Eldis Jobs</dc:creator>
				<category><![CDATA[#GHDjob]]></category>
		<category><![CDATA[Aid]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Delivery]]></category>
		<category><![CDATA[Family planning]]></category>
		<category><![CDATA[HIV/AIDS]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[hiv/aids]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/2013/05/10/iraq-humanitarian-programme-coordinator-erbil-iraq-arab-states-regional/</guid>
		<description><![CDATA[Organization: UN Population Fund Country: Iraq Closing date: 17 May 2013 We are pleased to announce the following vacancy: JOB ID NO: Job ID 2236 CLOSING DATE: 17 May 2013 (5:00 p.m. New York time) POST TITLE: Humanitarian Programme Coordinator CATEGORY: ICS-10 (equivalent to P-3) POST NUMBER: New POST TYPE: Non-rotational DUTY STATION: Erbil, Iraq DURATION: Temporary Appointment (364 days) ORGANIZATIONAL UNIT: Arab States Regional Office ORGANIZATIONAL SETTING: According to UNHCR data, more than 125,000 Syrian refugees are residing in Iraq, the number keeps growing and it is estimated that it will each more than 350,000 by the end of 2013, out of those, 66,500 are women of reproductive age, facing major complications due to lack or interruption of reproductive health services, including antenatal, postnatal and emergency obstetric care, not to mention family planning and other services that was part of RH package provided in Syria including early detection of cervical and breast cancers. UNFPA Iraq has been scaling up its humanitarian assistance to the Syrian refugees in North of Iraq (Kurdistan region) and South-West of Iraq (Anbar Governorates) since mid-2012. The intervention of Iraq CO is based on three main strategies: • Ensure accessibility of affected people to RH services and information including the emergency obstetric care through: a) deployment of staff to health facilities; b) procurement and delivery of RH commodities and pharmaceutical supplies, medical equipment and dignity kits; • Ensure accessibility of Syrian women and young girls (hosted in Refugee camps, as well those within hosting communities), in general, with particular focus on GBV survivors, to GBV Information and Psycho-Social Support and First Aid; • Facilitate sensitization and mobilization of Syrian youth (male and female), hosted in Refugee camps, as well those within hosting communities, on issues related to SRH, violence and GBV. ]]></description>
				<content:encoded><![CDATA[<p>Organization: UN Population Fund Country: Iraq Closing date: 17 May 2013 We are pleased to announce the following vacancy: JOB ID NO: Job ID 2236 CLOSING DATE: 17 May 2013 (5:00 p.m. New York time) POST TITLE: Humanitarian Programme Coordinator CATEGORY: ICS-10 (equivalent to P-3) POST NUMBER: New POST TYPE: Non-rotational DUTY STATION: Erbil, Iraq DURATION: Temporary Appointment (364 days) ORGANIZATIONAL UNIT: Arab States Regional Office ORGANIZATIONAL SETTING: According to UNHCR data, more than 125,000 Syrian refugees are residing in Iraq, the number keeps growing and it is estimated that it will each more than 350,000 by the end of 2013, out of those, 66,500 are women of reproductive age, facing major complications due to lack or interruption of reproductive health services, including antenatal, postnatal and emergency obstetric care, not to mention family planning and other services that was part of RH package provided in Syria including early detection of cervical and breast cancers. UNFPA Iraq has been scaling up its humanitarian assistance to the Syrian refugees in North of Iraq (Kurdistan region) and South-West of Iraq (Anbar Governorates) since mid-2012. The intervention of Iraq CO is based on three main strategies: • Ensure accessibility of affected people to RH services and information including the emergency obstetric care through: a) deployment of staff to health facilities; b) procurement and delivery of RH commodities and pharmaceutical supplies, medical equipment and dignity kits; • Ensure accessibility of Syrian women and young girls (hosted in Refugee camps, as well those within hosting communities), in general, with particular focus on GBV survivors, to GBV Information and Psycho-Social Support and First Aid; • Facilitate sensitization and mobilization of Syrian youth (male and female), hosted in Refugee camps, as well those within hosting communities, on issues related to SRH, violence and GBV. </p>
<p>Read the rest here:<br />
<a target="_blank" href="http://feedproxy.google.com/~r/eldis-jobs/~3/CTPgJfQpEF4/humanitarian-programme-coordinator-erbil-iraq-arab-states-regional-office-ics-10-p-3" title="Iraq: Humanitarian Programme Coordinator, Erbil, Iraq, Arab States Regional...">Iraq: Humanitarian Programme Coordinator, Erbil, Iraq, Arab States Regional&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/10/iraq-humanitarian-programme-coordinator-erbil-iraq-arab-states-regional/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Daily Impact: GAVI, GSK and Merck Team Up to Lower HPV Vaccine Cost</title>
		<link>http://www.globalhealthhub.org/2013/05/10/the-daily-impact-gavi-gsk-and-merck-team-up-to-lower-hpv-vaccine-cost/</link>
		<comments>http://www.globalhealthhub.org/2013/05/10/the-daily-impact-gavi-gsk-and-merck-team-up-to-lower-hpv-vaccine-cost/#comments</comments>
		<pubDate>Fri, 10 May 2013 14:17:00 +0000</pubDate>
		<dc:creator>PSIHealthyLives</dc:creator>
				<category><![CDATA[Aid]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[infectious disease]]></category>
		<category><![CDATA[malaria]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=95828</guid>
		<description><![CDATA[May 10, 2013 Millions of girls will have access to the lifesaving HPV vaccine thanks to a partnership between GAVI and Merck that will reduce the vaccine cost to below $5. From the New York Times: Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries. But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health. The World Health Organization, which has been pressing for faster progress in maternal health, greeted the news as “a great step forward for women and girls.” When the new price was described, Dr. ]]></description>
				<content:encoded><![CDATA[<p>May 10, 2013 Millions of girls will have access to the lifesaving HPV vaccine thanks to a partnership between GAVI and Merck that will reduce the vaccine cost to below $5. From the New York Times: Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries. But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health. The World Health Organization, which has been pressing for faster progress in maternal health, greeted the news as “a great step forward for women and girls.” When the new price was described, Dr. </p>
<p><img src="http://www.globalhealthhub.org/wp-content/uploads/2013/05/596c6792819478_ce19ec1b85_m-150x150.jpg" /></p>
<p>Go here to see the original:<br />
<a target="_blank" href="http://blog.psiimpact.com/2013/05/the-daily-impact-gavi-and-merck-team-up-to-lower-hpv-vaccine-cost/" title="The Daily Impact: GAVI, GSK and Merck Team Up to Lower HPV Vaccine Cost">The Daily Impact: GAVI, GSK and Merck Team Up to Lower HPV Vaccine Cost</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/10/the-daily-impact-gavi-gsk-and-merck-team-up-to-lower-hpv-vaccine-cost/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kenya: Rising Cancer Cases Worry Medics</title>
		<link>http://www.globalhealthhub.org/2013/05/10/kenya-rising-cancer-cases-worry-medics/</link>
		<comments>http://www.globalhealthhub.org/2013/05/10/kenya-rising-cancer-cases-worry-medics/#comments</comments>
		<pubDate>Fri, 10 May 2013 13:54:05 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=95900</guid>
		<description><![CDATA[As the world grapples with a myriad of problems, ranging from unfavourable climatic conditions and population pressure on resources, disease burden is arguably one monster that continues to destabilise the very essence of life. via allAfrica.com: Kenya: Rising Cancer Cases Worry Medics (Page 1 of 5).]]></description>
				<content:encoded><![CDATA[<p>As the world grapples with a myriad of problems, ranging from unfavourable climatic conditions and population pressure on resources, disease burden is arguably one monster that continues to destabilise the very essence of life.</p>
<p>via <a href="http://allafrica.com/stories/201305091207.html">allAfrica.com: Kenya: Rising Cancer Cases Worry Medics (Page 1 of 5)</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/10/kenya-rising-cancer-cases-worry-medics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The price of preventing cervical cancer</title>
		<link>http://www.globalhealthhub.org/2013/05/09/the-price-of-preventing-cervical-cancer/</link>
		<comments>http://www.globalhealthhub.org/2013/05/09/the-price-of-preventing-cervical-cancer/#comments</comments>
		<pubDate>Thu, 09 May 2013 14:19:00 +0000</pubDate>
		<dc:creator>SarahBoseley</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Financing]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[Policy & Systems]]></category>
		<category><![CDATA[cervical cancer]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=95678</guid>
		<description><![CDATA[The GAVI Alliance has announced that the cost of the HPV vaccine to developing countries, agreed with Merck and GSK, will be $4.50 a dose - a big discount on rich country prices but campaigners say it is too highCervical cancer vaccines for the developing world will cost $4.50 a dose, says the GAVI Alliance today. That is $13.50 per young woman, because each needs three shots. It is a small price to pay for preventing a disease which is a scourge of Africa and Asia - but the bill for immunising whole populations of schoolgirls will be huge.The price has been agreed between the GAVI Alliance - which channels money into vaccine programmes in poor countries - and the two major pharmaceutical companies that manufacture HPV vaccine. They are Merck, which makes Gardasil and GlaxoSmithKline, which makes Cervarix. The prices are a substantial discount on the cost to rich countries like the USA, France and the UK where immunisation programmes are in full swing]]></description>
				<content:encoded><![CDATA[<p>The GAVI Alliance has announced that the cost of the HPV vaccine to developing countries, agreed with Merck and GSK, will be $4.50 a dose &#8211; a big discount on rich country prices but campaigners say it is too highCervical cancer vaccines for the developing world will cost $4.50 a dose, says the GAVI Alliance today. That is $13.50 per young woman, because each needs three shots. It is a small price to pay for preventing a disease which is a scourge of Africa and Asia &#8211; but the bill for immunising whole populations of schoolgirls will be huge.The price has been agreed between the GAVI Alliance &#8211; which channels money into vaccine programmes in poor countries &#8211; and the two major pharmaceutical companies that manufacture HPV vaccine. They are Merck, which makes Gardasil and GlaxoSmithKline, which makes Cervarix. The prices are a substantial discount on the cost to rich countries like the USA, France and the UK where immunisation programmes are in full swing</p>
<p><img src="http://www.globalhealthhub.org/wp-content/uploads/2013/05/7f02Cervical-cancer-vaccine-007-150x150.jpg" /></p>
<p>Original post:<br />
<a target="_blank" href="http://www.guardian.co.uk/society/sarah-boseley-global-health/2013/may/09/vaccines-pharmaceuticals-industry" title="The price of preventing cervical cancer">The price of preventing cervical cancer</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/09/the-price-of-preventing-cervical-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV Doubles Risk For Cancer In Men</title>
		<link>http://www.globalhealthhub.org/2013/05/08/hiv-doubles-risk-for-cancer-in-men/</link>
		<comments>http://www.globalhealthhub.org/2013/05/08/hiv-doubles-risk-for-cancer-in-men/#comments</comments>
		<pubDate>Wed, 08 May 2013 13:51:25 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[HIV/AIDS]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Journal Watch]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=95553</guid>
		<description><![CDATA[Men with HIV have twice the chance of getting cancer compared to the general public, but combination antiretroviral therapies (cART) were effective at protecting the body to such a risk, a new study shows. via HIV Doubles Risk For Cancer In Men : US/World : Medical Daily.]]></description>
				<content:encoded><![CDATA[<p>Men with HIV have twice the chance of getting cancer compared to the general public, but combination antiretroviral therapies (cART) were effective at protecting the body to such a risk, a new study shows.</p>
<p>via <a href="http://www.medicaldaily.com/articles/15041/20130501/hiv-aids-risk-cancer-men-antiretroviral-immunology-diseases.htm#sfZY3ITrRdt4veU9.99">HIV Doubles Risk For Cancer In Men : US/World : Medical Daily</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/08/hiv-doubles-risk-for-cancer-in-men/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Urologists Recommend Less PSA Testing For Prostate Cancer</title>
		<link>http://www.globalhealthhub.org/2013/05/06/urologists-recommend-less-psa-testing-for-prostate-cancer/</link>
		<comments>http://www.globalhealthhub.org/2013/05/06/urologists-recommend-less-psa-testing-for-prostate-cancer/#comments</comments>
		<pubDate>Mon, 06 May 2013 12:51:54 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Delivery]]></category>
		<category><![CDATA[Featured Content]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[Policy & Systems]]></category>
		<category><![CDATA[prostate cancer]]></category>
		<category><![CDATA[PSA test]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=95047</guid>
		<description><![CDATA[The men and women who often treat prostate cancer are now recommending that the blood test commonly used to screen for it should be given a lot less often. via Urologists Recommend Less PSA Testing For Prostate Cancer : Shots &#8211; Health News : NPR.]]></description>
				<content:encoded><![CDATA[<p>The men and women who often treat prostate cancer are now recommending that the blood test commonly used to screen for it should be given a lot less often.</p>
<p>via <a href="http://www.npr.org/blogs/health/2013/05/03/180871950/urologists-recommend-less-psa-testing-for-prostate-cancer">Urologists Recommend Less PSA Testing For Prostate Cancer : Shots &#8211; Health News : NPR</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/06/urologists-recommend-less-psa-testing-for-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Breast cancer rates increase among younger women &#124; Society &#124; The Guardian</title>
		<link>http://www.globalhealthhub.org/2013/05/03/breast-cancer-rates-increase-among-younger-women-society-the-guardian/</link>
		<comments>http://www.globalhealthhub.org/2013/05/03/breast-cancer-rates-increase-among-younger-women-society-the-guardian/#comments</comments>
		<pubDate>Fri, 03 May 2013 12:01:51 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Featured Content]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[breast cancer]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=94760</guid>
		<description><![CDATA[A record number of women under 50 are being diagnosed with breast cancer in the UK, a charity has warned. via Breast cancer rates increase among younger women &#124; Society &#124; The Guardian.]]></description>
				<content:encoded><![CDATA[<p>A record number of women under 50 are being diagnosed with breast cancer in the UK, a charity has warned.</p>
<p>via <a href="http://www.guardian.co.uk/society/2013/may/03/breast-cancer-increase-younger-women">Breast cancer rates increase among younger women | Society | The Guardian</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/03/breast-cancer-rates-increase-among-younger-women-society-the-guardian/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>News from the Front in War on Cancer&#8211;Mission Not Accomplished</title>
		<link>http://www.globalhealthhub.org/2013/05/02/news-from-the-front-in-war-on-cancer-mission-not-accomplished/</link>
		<comments>http://www.globalhealthhub.org/2013/05/02/news-from-the-front-in-war-on-cancer-mission-not-accomplished/#comments</comments>
		<pubDate>Thu, 02 May 2013 14:31:50 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Featured Content]]></category>
		<category><![CDATA[Hub Selects]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=94560</guid>
		<description><![CDATA[Genetic sequencing has dumped a mountain of data into researchers laps, but it hasnt yielded a silver bullet to cure cancer via News from the Front in War on Cancer&#8211;Mission Not Accomplished: Scientific American.]]></description>
				<content:encoded><![CDATA[<p>Genetic sequencing has dumped a mountain of data into researchers laps, but it hasnt yielded a silver bullet to cure cancer</p>
<p>via <a href="http://www.scientificamerican.com/article.cfm?id=news-from-cancer-war">News from the Front in War on Cancer&#8211;Mission Not Accomplished: Scientific American</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/02/news-from-the-front-in-war-on-cancer-mission-not-accomplished/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young WomenA Randomized Clinical TrialImmunogenicity of HPV Vaccine in Girls vs Women</title>
		<link>http://www.globalhealthhub.org/2013/05/01/immunogenicity-of-2-doses-of-hpv-vaccine-in-younger-adolescents-vs-3-doses-in-young-womena-randomized-clinical-trialimmunogenicity-of-hpv-vaccine-in-girls-vs-women/</link>
		<comments>http://www.globalhealthhub.org/2013/05/01/immunogenicity-of-2-doses-of-hpv-vaccine-in-younger-adolescents-vs-3-doses-in-young-womena-randomized-clinical-trialimmunogenicity-of-hpv-vaccine-in-girls-vs-women/#comments</comments>
		<pubDate>Wed, 01 May 2013 13:10:12 +0000</pubDate>
		<dc:creator>GHHub</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Journal Watch]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[HPV]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=94292</guid>
		<description><![CDATA[Globally, cervical cancer is the second most common cause of cancer morbidity and mortality in women.1 Human papillomavirus HPV infection has been identified as a necessary cause for the development of cervical cancer, with HPV genotypes 16 and 18 accounting for approximately 70% of cervical cancer cases. Prevention of cervical cancer using either the bivalent [...]]]></description>
				<content:encoded><![CDATA[<p>Globally, cervical cancer is the second most common cause of cancer morbidity and mortality in women.1 Human papillomavirus HPV infection has been identified as a necessary cause for the development of cervical cancer, with HPV genotypes 16 and 18 accounting for approximately 70% of cervical cancer cases. Prevention of cervical cancer using either the bivalent HPV-16 and HPV-18 or quadrivalent HPV-6, HPV-11, HPV-16, and HPV-18 vaccine is the goal of immunization programs in many countries. Both vaccines are safe, highly immunogenic, and effective at protecting against persistent infection and disease. The HPV vaccines, which are designed to prevent cervical cancer outcomes in adults, need to be administered before persons become sexually active.</p>
<p>via <a href="http://jama.jamanetwork.com/article.aspx?articleid=1682939">JAMA Network | JAMA | Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young WomenA Randomized Clinical TrialImmunogenicity of HPV Vaccine in Girls vs Women</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/05/01/immunogenicity-of-2-doses-of-hpv-vaccine-in-younger-adolescents-vs-3-doses-in-young-womena-randomized-clinical-trialimmunogenicity-of-hpv-vaccine-in-girls-vs-women/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>At Library Dedication, U.S. Presidents Praise Bush For Work On HIV/AIDS,&#8230;</title>
		<link>http://www.globalhealthhub.org/2013/04/29/at-library-dedication-u-s-presidents-praise-bush-for-work-on-hivaids/</link>
		<comments>http://www.globalhealthhub.org/2013/04/29/at-library-dedication-u-s-presidents-praise-bush-for-work-on-hivaids/#comments</comments>
		<pubDate>Mon, 29 Apr 2013 22:03:00 +0000</pubDate>
		<dc:creator>Kaiser GH Update</dc:creator>
				<category><![CDATA[Aid]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[HIV/AIDS]]></category>
		<category><![CDATA[Kaiser's Global Health Update]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[hiv/aids]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/2013/04/29/at-library-dedication-u-s-presidents-praise-bush-for-work-on-hivaids/</guid>
		<description><![CDATA[Last week, "[t]he George W. Bush Presidential Library dedication brought together five living presidents who have been at odds about much of the 43rd president's foreign policy legacy, particularly the Iraq war ... [b]ut they all agreed on, and offered effusive praise for, Bush's work on Africa," ABC News' "The Note" blog reports. "From the historic peace agreement between Sudan and South Sudan in 2005, to Bush's work on HIV/AIDS and malaria, all the presidents, regardless of party, thanked No. 43 for his involvement in African policies and issues," the blog states, noting, "His administration's aid was largely targeted to fight the major global health issues facing the continent, HIV/AIDS and malaria." ABC News discusses the creation of PEPFAR and the President's Malaria Initiative and includes comments from some of the speakers at the dedication. ]]></description>
				<content:encoded><![CDATA[<p>Last week, &#8220;[t]he George W. Bush Presidential Library dedication brought together five living presidents who have been at odds about much of the 43rd president&#8217;s foreign policy legacy, particularly the Iraq war &#8230; [b]ut they all agreed on, and offered effusive praise for, Bush&#8217;s work on Africa,&#8221; ABC News&#8217; &#8220;The Note&#8221; blog reports. &#8220;From the historic peace agreement between Sudan and South Sudan in 2005, to Bush&#8217;s work on HIV/AIDS and malaria, all the presidents, regardless of party, thanked No. 43 for his involvement in African policies and issues,&#8221; the blog states, noting, &#8220;His administration&#8217;s aid was largely targeted to fight the major global health issues facing the continent, HIV/AIDS and malaria.&#8221; ABC News discusses the creation of PEPFAR and the President&#8217;s Malaria Initiative and includes comments from some of the speakers at the dedication. </p>
<p>Excerpt from:<br />
<a target="_blank" href="http://feeds.kff.org/~r/kff/kdghpr/~3/EIGp14dajcI/GH-042913-Presidents-Praise-Bush.aspx" title="At Library Dedication, U.S. Presidents Praise Bush For Work On HIV/AIDS,...">At Library Dedication, U.S. Presidents Praise Bush For Work On HIV/AIDS,&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/04/29/at-library-dedication-u-s-presidents-praise-bush-for-work-on-hivaids/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>This Week in PLOS Medicine: Atherosclerosis &amp; Air Pollution,&#8230;</title>
		<link>http://www.globalhealthhub.org/2013/04/24/this-week-in-plos-medicine-atherosclerosis-air-pollution/</link>
		<comments>http://www.globalhealthhub.org/2013/04/24/this-week-in-plos-medicine-atherosclerosis-air-pollution/#comments</comments>
		<pubDate>Wed, 24 Apr 2013 15:48:00 +0000</pubDate>
		<dc:creator>PLoS Medicine Blog</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Journal Watch]]></category>
		<category><![CDATA[Noncommunicable Disease]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[general]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/?p=93469</guid>
		<description><![CDATA[Flikr Jennifer Barnard This week PLOS Medicine published articles ranging from research on the link between air pollution and atherosclerosis to a case study of the Scottish alcohol industry’s effect on public policy. In a prospective cohort study, Sara Adar and colleagues found that decreasing levels of fine particulate matter in multiple US urban areas are associated with slowed progression of intima-medial thickness, a surrogate measure of atherosclerosis. Nino Künzli contextualized these findings as some of the first human evidence for the impact of air pollution on the development of atherosclerosis. In a prospective study, Jiali Han and colleagues found a modestly increased risk of subsequent malignancies among individuals with a history of non-melanoma skin cancer, specifically breast and lung cancer in women and melanoma in both men and women. ]]></description>
				<content:encoded><![CDATA[<p><img src="http://www.globalhealthhub.org/wp-content/uploads/2013/04/0e65blog-150x150.jpg" /></p>
<p>Flikr Jennifer Barnard This week PLOS Medicine published articles ranging from research on the link between air pollution and atherosclerosis to a case study of the Scottish alcohol industry’s effect on public policy. In a prospective cohort study, Sara Adar and colleagues found that decreasing levels of fine particulate matter in multiple US urban areas are associated with slowed progression of intima-medial thickness, a surrogate measure of atherosclerosis. Nino Künzli contextualized these findings as some of the first human evidence for the impact of air pollution on the development of atherosclerosis. In a prospective study, Jiali Han and colleagues found a modestly increased risk of subsequent malignancies among individuals with a history of non-melanoma skin cancer, specifically breast and lung cancer in women and melanoma in both men and women. </p>
<p>Read the article:</p>
<p><a target="_blank" href="http://feeds.plos.org/~r/plos/MedicineBlog/~3/0Mz3B0HoaFg/" title="This Week in PLOS Medicine: Atherosclerosis &amp; Air Pollution,...">This Week in PLOS Medicine: Atherosclerosis &amp; Air Pollution,&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/04/24/this-week-in-plos-medicine-atherosclerosis-air-pollution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>South Africa Aims To Close Drug Patent Loophole That Allows For&#8230;</title>
		<link>http://www.globalhealthhub.org/2013/04/23/south-africa-aims-to-close-drug-patent-loophole-that-allows-for/</link>
		<comments>http://www.globalhealthhub.org/2013/04/23/south-africa-aims-to-close-drug-patent-loophole-that-allows-for/#comments</comments>
		<pubDate>Tue, 23 Apr 2013 21:45:00 +0000</pubDate>
		<dc:creator>Kaiser GH Update</dc:creator>
				<category><![CDATA[Aid]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Kaiser's Global Health Update]]></category>
		<category><![CDATA[aid]]></category>
		<category><![CDATA[cancer]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/2013/04/23/south-africa-aims-to-close-drug-patent-loophole-that-allows-for/</guid>
		<description><![CDATA["South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior official said on Monday," Reuters reports. The efforts to close "a loophole known as 'ever-greening,' whereby drug companies slightly modify an existing drug whose patent is about to expire and then claim it is a new drug, thereby extending its patent protection and their profits," would need to be approved by parliament, the news service notes. MacDonald Netshitenzhe, head of policy at the Department of Trade and Industry, "said South Africa, an emerging economy with pressing public health needs, wanted to improve access to medicines, including generics, and was ready should drug firms come out fighting against the proposed patent law changes," according to Reuters. The news service notes "South Africa's position was supported this month by a ruling from India's top court that dismissed an application by Swiss drug maker Novartis AG to win patent protection for its Glivec cancer drug" (Roelf, 4/22).]]></description>
				<content:encoded><![CDATA[<p>&#8220;South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior official said on Monday,&#8221; Reuters reports. The efforts to close &#8220;a loophole known as &#8216;ever-greening,&#8217; whereby drug companies slightly modify an existing drug whose patent is about to expire and then claim it is a new drug, thereby extending its patent protection and their profits,&#8221; would need to be approved by parliament, the news service notes. MacDonald Netshitenzhe, head of policy at the Department of Trade and Industry, &#8220;said South Africa, an emerging economy with pressing public health needs, wanted to improve access to medicines, including generics, and was ready should drug firms come out fighting against the proposed patent law changes,&#8221; according to Reuters. The news service notes &#8220;South Africa&#8217;s position was supported this month by a ruling from India&#8217;s top court that dismissed an application by Swiss drug maker Novartis AG to win patent protection for its Glivec cancer drug&#8221; (Roelf, 4/22).</p>
<p>Go here to read the rest:<br />
<a target="_blank" href="http://feeds.kff.org/~r/kff/kdghpr/~3/BcD82lW-wSE/GH-042313-South-Africa-Patent-Loophole.aspx" title="South Africa Aims To Close Drug Patent Loophole That Allows For...">South Africa Aims To Close Drug Patent Loophole That Allows For&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/04/23/south-africa-aims-to-close-drug-patent-loophole-that-allows-for/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indian Drug Supplier Cuts Price Of 5-In-1 Childhood Vaccine For GAVI&#8230;</title>
		<link>http://www.globalhealthhub.org/2013/04/18/indian-drug-supplier-cuts-price-of-5-in-1-childhood-vaccine-for-gavi/</link>
		<comments>http://www.globalhealthhub.org/2013/04/18/indian-drug-supplier-cuts-price-of-5-in-1-childhood-vaccine-for-gavi/#comments</comments>
		<pubDate>Thu, 18 Apr 2013 21:10:00 +0000</pubDate>
		<dc:creator>Kaiser GH Update</dc:creator>
				<category><![CDATA[Aid]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Kaiser's Global Health Update]]></category>
		<category><![CDATA[aid]]></category>
		<category><![CDATA[cancer]]></category>

		<guid isPermaLink="false">http://www.globalhealthhub.org/2013/04/18/indian-drug-supplier-cuts-price-of-5-in-1-childhood-vaccine-for-gavi/</guid>
		<description><![CDATA["The cost of immunizing children in developing countries with a five-in-one vaccine is set to fall after a deal by an Indian supplier to slash the price it charges the GAVI global vaccines group," Reuters reports. "GAVI said on Thursday that Biological E would sell the pentavalent shot for $1.19 per dose, compared to a 2012 weighted average price of $2.17, saving it up to $150 million over the next four years," the news service writes, noting the five-in-one vaccine "protects against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenzae type B (Hib)." The news service adds, "The agreement between Biological E and the GAVI Alliance, which funds bulk-buy vaccination programs for poor nations, highlights the growing role of India's low-cost drugs sector in supplying products around the world," noting, "India's staunch support for its generics sector has led to clashes with Western pharmaceutical companies, most recently following a high-profile defeat for Novartis in a cancer drug patent case this month" (Hirschler, 4/17).]]></description>
				<content:encoded><![CDATA[<p>&#8220;The cost of immunizing children in developing countries with a five-in-one vaccine is set to fall after a deal by an Indian supplier to slash the price it charges the GAVI global vaccines group,&#8221; Reuters reports. &#8220;GAVI said on Thursday that Biological E would sell the pentavalent shot for $1.19 per dose, compared to a 2012 weighted average price of $2.17, saving it up to $150 million over the next four years,&#8221; the news service writes, noting the five-in-one vaccine &#8220;protects against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenzae type B (Hib).&#8221; The news service adds, &#8220;The agreement between Biological E and the GAVI Alliance, which funds bulk-buy vaccination programs for poor nations, highlights the growing role of India&#8217;s low-cost drugs sector in supplying products around the world,&#8221; noting, &#8220;India&#8217;s staunch support for its generics sector has led to clashes with Western pharmaceutical companies, most recently following a high-profile defeat for Novartis in a cancer drug patent case this month&#8221; (Hirschler, 4/17).</p>
<p>Read this article:<br />
<a target="_blank" href="http://feeds.kff.org/~r/kff/kdghpr/~3/J5y4HOuOpCc/GH-041813-GAVI-Vaccine-Price.aspx" title="Indian Drug Supplier Cuts Price Of 5-In-1 Childhood Vaccine For GAVI...">Indian Drug Supplier Cuts Price Of 5-In-1 Childhood Vaccine For GAVI&#8230;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.globalhealthhub.org/2013/04/18/indian-drug-supplier-cuts-price-of-5-in-1-childhood-vaccine-for-gavi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
